MIRM Q2 earnings miss estimates while revenues beat the same, as Livmarli and bile acid drugs fuel g

Mirum Pharmaceuticals, Inc. (MIRM) Q2 2026 Earnings Call Transcript

Mirum Pharmaceuticals NASDAQ: MIRM reported second-quarter net product sales of $176 million and rai

The headline numbers for Mirum Pharmaceuticals (MIRM) give insight into how the company performed in

Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.8 per share versus the Zacks

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Re

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Announce Second Quarter 2026 Financia

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq L

Mirum Pharmaceuticals is evolving into a leading liver disease franchise, with robust revenue growth

Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being high

After a sweeping semi-annual rebalance, the biotech index underlying the ALPS Medical Breakthroughs

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begin

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begin

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begin

Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced pivotal Phase 2 r

FOSTER CITY, Calif. & WILMINGTON, Del.--(BUSINESS WIRE)--Mirum Pharmaceuticals and Incyte Announce P

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq L

Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock?

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Ph

FOSTER CITY, Calif. & WILMINGTON, Del.--(BUSINESS WIRE)--Mirum and Incyte Announce Pivotal Late-Brea

Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. Se

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earn

Gainers

U.S. stocks closed lower on Wednesday, with the Dow Jones dipping more than 600 points. Here is the

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report

  Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earn

  Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report q

  Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly e

Stocks That Hit 52-Week Highs On Wednesday

Stocks That Hit 52-Week Highs On Tuesday

Stocks that Broke 52-Week Highs Tuesday